2004
DOI: 10.1091/mbc.e04-06-0461
|View full text |Cite
|
Sign up to set email alerts
|

The LC7 Light Chains ofChlamydomonasFlagellar Dyneins Interact with Components Required for Both Motor Assembly and Regulation

Abstract: Members of the LC7/Roadblock family of light chains (LCs) have been found in both cytoplasmic and axonemal dyneins. LC7a was originally identified within Chlamydomonas outer arm dynein and associates with this motor's cargo-binding region. We describe here a novel member of this protein family, termed LC7b that is also present in the Chlamydomonas flagellum. Levels of LC7b are reduced approximately 20% in axonemes isolated from strains lacking inner arm I1 and are approximately 80% lower in the absence of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
57
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 64 publications
(59 citation statements)
references
References 76 publications
(98 reference statements)
2
57
0
Order By: Relevance
“…The ODA-DC molecules cooperatively bind to the doublet in an end-toend manner and establish a 24-nm periodicity. Subsequently, OAD binds to the outer doublet through its association with the ODA-DCs on the doublet, and this interaction is stabilized through the direct interaction of IC1 with the microtubule, thereby establishing the 24-nm periodicity in the OAD arrangement (24,25,29,30).…”
Section: In Vitro Cooperative Binding To Microtubules Observed By Micmentioning
confidence: 99%
See 1 more Smart Citation
“…The ODA-DC molecules cooperatively bind to the doublet in an end-toend manner and establish a 24-nm periodicity. Subsequently, OAD binds to the outer doublet through its association with the ODA-DCs on the doublet, and this interaction is stabilized through the direct interaction of IC1 with the microtubule, thereby establishing the 24-nm periodicity in the OAD arrangement (24,25,29,30).…”
Section: In Vitro Cooperative Binding To Microtubules Observed By Micmentioning
confidence: 99%
“…Defects in CCDC114 are known to cause PCD and the patients lack outer dynein arms, suggesting that DC2 functions in OAD docking in humans also (22,23). The ODA-DC binds OAD via at least three interactions: one between DC1 and the OAD intermediate chain IC1, one between DC1 and the other OAD intermediate chain IC2, and one between DC2 and the OAD light chain LC7b (24,25). However, we still do not understand the architecture of the ODA-DC and the detailed manner of its binding to the doublet microtubules, which will be essential for understanding the molecular basis of OAD periodicity.…”
mentioning
confidence: 99%
“…After demembranation with 1% IGEPAL CA-630 (replaces Nonidet P-40), dynein was extracted from the resulting axonemes by treatment with 0.6 M NaCl. The outer arm and associated docking complex were then purified by sucrose density gradient centrifugation in the presence of Mg 2ϩ at low hydrostatic pressure (Takada et al, 1992;DiBella et al, 2004a). Samples were routinely electrophoresed in 5-15% acrylamide SDS gradient gels or 12.5% acrylamide slab gels and either stained with Coomassie blue or transferred to nitrocellulose for immunoblotting.…”
Section: Fractionation Of Flagella and Dynein Purificationmentioning
confidence: 99%
“…Other antibodies used in this study were blot-purified rabbit polyclonal antibodies R5932 (vs. LC1; Benashski et al, 1999), R5391 (vs. LC2;Patel-King et al, 1997), R4930 (vs. LC3;Patel-King et al, 1996), CT61 (vs. LC4; M. Sakato and King, unpublished data), R4929 (vs. LC5;Patel-King et al, 1996), R4928 (vs. LC6; King and Patel-King, 1995), R7178 (vs. LC7a;Bowman et al, 1999), CT116 (vs. LC7b;DiBella et al, 2004a), R4058 (vs. LC8; King and Patel-King, 1995), and anti-DC 2 (Wakabayashi et al, 2001), and mouse monoclonal antibodies 12␥B (vs. ␥ HC; King et al, 1985), 1878A (vs. IC1; King et al, 1986), and 1869A (vs. IC2; King et al, 1985). Antibody reactivity was detected using peroxidase-conjugated secondary antibodies and an enhanced chemiluminescent substrate (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).…”
Section: Preparation Of Fusion Proteins and Antibodiesmentioning
confidence: 99%
See 1 more Smart Citation